Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs
Author:
Publisher
Springer Science and Business Media LLC
Subject
Parasitology
Link
http://link.springer.com/content/pdf/10.1007/s12639-011-0040-9.pdf
Reference82 articles.
1. Al-Abdely HM, Graybill JR, Loebenberg D, Melby PC (1999) Efficacy of the triazole SCH 56592 against L. amazonensis and L. donovani in experimental murine cutaneous and visceral leishmaniases. Antimicrob Agents Chemother 43:2910–2914
2. Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH (2002) Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 346:891–895
3. Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev 3:673–683
4. Beach DH, Goad LJ, Holz GG Jr (1998) Effects of antimycotic azoles on growth and sterol biosynthesis of leishmania promastigotes. Mol Biochem Parasitol 31:149–162
5. Bekersky I, Fielding RM, Dressler DE, Lee JW, Buell DN, Walsh TJ (2002) Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans. Antimicrob Agents Chemother 46:828–833
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Compounds with potentialities as novel chemotherapeutic agents in leishmaniasis at preclinical level;Experimental Parasitology;2024-05
2. Advances in Antileishmanial Chemotherapy;Challenges and Solutions Against Visceral Leishmaniasis;2023
3. Amino acid containing amphiphilic hydrogelators with antibacterial and antiparasitic activities;Soft Matter;2022
4. Bioprospecting marine actinomycetes for antileishmanial drugs: current perspectives and future prospects;Heliyon;2021-08
5. Unravelling the myth surrounding sterol biosynthesis as plausible target for drug design against leishmaniasis;Journal of Parasitic Diseases;2021-04-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3